The XIVth International Symposium on Amyloidosis
Amyloid: Insoluble, but solvable
The XIVth International Symposium on Amyloidosis will meet in Indianapolis, Indiana from 27 April to 1 May, 2014. The ISA Symposium returns to the United States after very successful meetings in Groningen, The Netherlands and Rome, Italy. We hope we are able to continue the standard of successful meetings set by our predecessors.
This Symposium will allow for presentation and discussion of research on all types of amyloidosis. Amyloid and amyloidosis are generic terms referring to the deposition of protein fibrils with certain shared characteristics and, therefore, relate to a wide spectrum of diseases.
Plasma cell dyscrasia, chronic inflammation, and mutations in a number of plasma proteins can all lead to the final product, amyloid fibrils, which damage normal tissues and cause organ dysfunction. How each pathologic process gets to this final common denominator (pathogenesis) is a most important subject for review and discussion.
Research on medical interventions (therapeutics) to correct pathologic pathways or to reverse the effects of organ damage is also of prime importance. A major focus of the Symposium is to give a forum for presentation and discussion of emerging therapies for all types of amyloidosis.
The scientific program will include oral and poster presentations on all aspects of amyloidosis. Oral presentations give a chance to focus on one aspect of a subject while posters often lead to more lengthy discussions and sharing of ideas. This is important for both senior and junior investigators. The amyloidoses represent major diseases which affect many organ systems and draw experts in all fields of medicine, physics, and chemistry together to try to answer difficult questions.
We look forward to seeing you in Indianapolis!